Profil bibliographique

Salim Kanoun

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

102Publications signalées

2097Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Lymphoma Diagnosis and TreatmentMedical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical ImagingLung Cancer Treatments and MutationsCAR-T cell therapy research

Publications récentes

2026 articleOpenAlex

Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study

Yassine Al Tabaa, Clément Bailly, Xavier Palard-Novello, Anne-Ségolène Cottereau et autres

0 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

Accès ouvert 2026 preprintOpenAlex

Deep Learning-Based Whole-Body Lesion Segmentation and Automated OMIS Computation on [68Ga]Ga-DOTA-TOC PET/CT: Technical Feasibility of a SwinUNETR Pipeline for Pre-PRRT Bone Marrow Involvement Scoring

Romain Ferrara, Solène Malmon, Salim Kanoun, Joris Cocquebert et autres

0 citationsResearch Square

Accès ouvert 2025 articleOpenAlex

Large B-cell lymphoma: The LYSA pragmatic guidelines

Pierre Sesques, Guillaume Manson, Sydney Dubois, François‐Xavier Gros et autres

2 citationsEuropean Journal of Cancer

Accès ouvert 2025 conference-abstractOpenAlex

Treatment options, responses and outcome of 1220 classic Hodgkin lymphoma patients included in realysa, a prospective multicentric lysa cohort

Hervé Ghesquières, Catherine Thiéblemont, Aurélien Belot, Cécile Borel et autres

1 citationBlood

Accès ouvert 2025 articleOpenAlex

12 | IMAGING BIOMARKERS FOR THE DEFINITION OF RESPONSE IN THE GHSG HD18, GHSG HD21 AND LYSA AHL2011 TRIALS FOR ADVANCED‐STAGE HODGKIN LYMPHOMA

Justin Ferdinandus, C. Rossi, Helen Kaul, S. Leiders et autres

0 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

22 | PROGNOSTIC VALUE OF BASELINE TOTAL METABOLIC TUMOR VOLUME (TMTV) AND TUMOR SPREAD (Dmax) IN ADVANCED HODGKIN LYMPHOMA: ANCILLARY STUDY OF THE AHL2011 TRIAL

Salim Kanoun, Anne‐Ségolène Cottereau, C. Rossi, Caroline Rossoni et autres

0 citationsHematological Oncology

2025 articleOpenAlex

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials

S. Malmon, Mad‐Hélénie Elsensohn, Catherine Thieblemont, Franck Morschhauser et autres

8 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

Accès ouvert 2025 articleOpenAlex

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma

Vincent Camus, Thierry Jo Molina, Fabienne Desmots, Paul Blanc‐Durand et autres

6 citationsBlood Advances

2025 articleOpenAlex

Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study

S. Malmon, Olivier Casasnovas, Marguerite Fournier, Guillaume Cartron et autres

1 citationEuropean Journal of Nuclear Medicine and Molecular Imaging

Accès ouvert 2024 conference-abstractOpenAlex

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots, Amine Moslemi et autres

2 citationsBlood

Accès ouvert 2024 conference-abstractOpenAlex

Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma

Catherine Thieblemont, François‐Xavier Gros, Sandrine Roulland, Salim Kanoun et autres

1 citationBlood

Accès ouvert 2024 articleOpenAlex

Precautions to Consider in the Analysis of Prognostic and Predictive Indices

Loïc Chartier, Aurélien Belot, Isabelle Chaillol, Mad-Hélénie Elsensohn et autres

0 citationsJournal of Nuclear Medicine

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.